IdentificationGeneric Name(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OLDrugBank Accession NumberDB07647BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL (DB07647)× CloseWeightAverage: 344.4097 Monoisotopic: 344.163711282 Chemical FormulaC21H20N4OSynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUSerine/threonine-protein kinase Chk1Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as phenylpyrroles. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrrole ring through a CC or CN bond.KingdomOrganic compoundsSuper ClassOrganoheterocyclic compoundsClassPyrrolesSub ClassSubstituted pyrrolesDirect ParentPhenylpyrrolesAlternative ParentsPyrrolo[2,3-d]pyrimidines / Secondary alkylarylamines / Aminopyrimidines and derivatives / Imidolactams / Benzene and substituted derivatives / Heteroaromatic compounds / Secondary alcohols / Azacyclic compounds / Organopnictogen compounds / Hydrocarbon derivativesSubstituents2-phenylpyrrole / 3-phenylpyrrole / Alcohol / Amine / Aminopyrimidine / Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Heteroaromatic compound / Hydrocarbon derivativeMolecular FrameworkAromatic heteropolycyclic compoundsExternal Descriptorspyrrolopyrimidine (CHEBI:41931) Affected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyVBASHTSSQNDDAS-CQSZACIVSA-NInChIInChI=1S/C21H20N4O/c1-14(26)12-22-20-18-17(15-8-4-2-5-9-15)19(16-10-6-3-7-11-16)25-21(18)24-13-23-20/h2-11,13-14,26H,12H2,1H3,(H2,22,23,24,25)/t14-/m1/s1IUPAC Name(2R)-1-({5,6-diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)propan-2-olSMILES[H][C@](C)(O)CNC1=C2C(NC(=C2C2=CC=CC=C2)C2=CC=CC=C2)=NC=N1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound4369434PubChem Substance99444118ChemSpider3571996ZINCZINC000006416413PDBe LigandDF1PDB Entries2brnClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.00744 mg/mLALOGPSlogP3.93ALOGPSlogP3.52ChemaxonlogS-4.7ALOGPSpKa (Strongest Acidic)12.28ChemaxonpKa (Strongest Basic)6.31ChemaxonPhysiological Charge1ChemaxonHydrogen Acceptor Count4ChemaxonHydrogen Donor Count3ChemaxonPolar Surface Area73.83 Å2ChemaxonRotatable Bond Count5ChemaxonRefractivity105.13 m3·mol-1ChemaxonPolarizability37.69 Å3ChemaxonNumber of Rings4ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9971Blood Brain Barrier+0.8722Caco-2 permeable-0.6261P-glycoprotein substrateSubstrate0.5404P-glycoprotein inhibitor INon-inhibitor0.715P-glycoprotein inhibitor IIInhibitor0.7777Renal organic cation transporterNon-inhibitor0.8738CYP450 2C9 substrateNon-substrate0.7191CYP450 2D6 substrateNon-substrate0.8099CYP450 3A4 substrateNon-substrate0.6046CYP450 1A2 substrateInhibitor0.5817CYP450 2C9 inhibitorNon-inhibitor0.8236CYP450 2D6 inhibitorInhibitor0.5845CYP450 2C19 inhibitorNon-inhibitor0.5646CYP450 3A4 inhibitorNon-inhibitor0.7362CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.6534Ames testNon AMES toxic0.6399CarcinogenicityNon-carcinogens0.8149BiodegradationNot ready biodegradable0.9893Rat acute toxicity2.8128 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9101hERG inhibition (predictor II)Non-inhibitor0.5647  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Serine/threonine-protein kinase Chk1KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionProtein serine/threonine kinase activitySpecific FunctionSerine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. May also nega...Gene NameCHEK1Uniprot IDO14757Uniprot NameSerine/threonine-protein kinase Chk1Molecular Weight54433.115 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:24 / Updated at June 12, 2020 16:52 